Pathophysiology (Dec 2021)

Small Fiber Neuropathy in Sarcoidosis

  • Natalia Gavrilova,
  • Anna Starshinova,
  • Yulia Zinchenko,
  • Dmitry Kudlay,
  • Valeria Shapkina,
  • Anna Malkova,
  • Ekaterina Belyaeva,
  • Maria Pavlova,
  • Piotr Yablonskiy,
  • Yehuda Shoenfeld

DOI
https://doi.org/10.3390/pathophysiology28040035
Journal volume & issue
Vol. 28, no. 4
pp. 544 – 550

Abstract

Read online

Sarcoidosis (SC) is a granulomatous disease of an unknown origin. The most common SC-related neurological complication is a small fiber neuropathy (SFN) that is often considered to be the result of chronic inflammation and remains significantly understudied. This study aimed to identify the clinical and histological correlates of small fiber neuropathy in sarcoidosis patients. The study was performed in 2018–2019 yy and included 50 patients with pulmonary sarcoidosis (n = 25) and healthy subjects (n = 25). For the clinical verification of the SFN, the “Small Fiber Neuropathy Screening List” (SFN-SL) was used. A punch biopsy of the skin was performed followed by enzyme immunoassay analysis with PGP 9.5 antibodies. Up to 60% of the sarcoidosis patients reported the presence of at least one complaint, and it was possible that these complaints were associated with SFN. The most frequent complaints included dysfunctions of the cardiovascular and musculoskeletal systems and the gastrointestinal tract. A negative, statistically significant correlation between the intraepidermal nerve fiber density (IEND) and SFN-SL score was revealed. In patients with pulmonary sarcoidosis, small fiber neuropathy might develop as a result of systemic immune-mediated inflammation. The most common symptoms of this complication were dysautonomia and mild sensory dysfunction.

Keywords